Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Bimagrumab (Synonyms: LY-3985863, LY3985863, LY 3985863, BYM-338, BYM338, BYM 338, Anti-ACVR2B Reference A...)

Catalog No. T76860 Copy Product Info
Purity: 98%
🥰Excellent
Hot
Bimagrumab (BYM338) is a human monoclonal antibody that binds to the activin type II receptor. Bimagrumab can be used to study diabetes and obesity.

Bimagrumab

Copy Product Info
🥰Excellent
Hot
Catalog No. T76860
Synonyms LY-3985863, LY3985863, LY 3985863, BYM-338, BYM338, BYM 338, Anti-ACVR2B Reference Antibody

Bimagrumab (BYM338) is a human monoclonal antibody that binds to the activin type II receptor. Bimagrumab can be used to study diabetes and obesity.

Bimagrumab
Cas No. 1356922-05-8
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$263In StockIn Stock
5 mg$662In StockIn Stock
10 mg$1,060-In Stock
25 mg$1,570-In Stock
50 mg$2,120-In Stock
100 mg$2,860-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
Custom-made molecule. TargetMol’s expert synthesis team delivers cost-effective solutions. Contact us for inquiries. Committed to serving you.
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:100% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information

Product Introduction

Bioactivity
Description
Bimagrumab (BYM338) is a human monoclonal antibody that binds to the activin type II receptor. Bimagrumab can be used to study diabetes and obesity.
Targets&IC50
ACVR2A:434 pM (Kd), ACVR2B:1.7 pM (Kd)
In vitro
b>METHODS: Bimagrumab (Anti-ACVR2B Reference Antibody) (1 pM-1 μM) was used to treat HEK293 cells and its potency in inhibiting ActRII ligand signaling was evaluated in a Smad2/3 CAGA-luciferase reporter assay.
RESULTS: Bimagrumab (Anti-ACVR2B Reference Antibody) showed similar dose-dependent inhibition of activin A-induced luciferase with an IC50 value of 343 ± 97 pM. [1]
In vivo
b>METHODS: Bimagrumab (Anti-ACVR2B Reference Antibody) (6, 20 mg/kg, subcutaneous injection) was used to treat mice and body weight was measured weekly to study its use in naive mice.
RESULTS: Bimagrumab promoted weight gain and skeletal muscle hypertrophy in all examined mouse muscles, including slow, fast, and mixed muscles. [1]
SynonymsLY-3985863, LY3985863, LY 3985863, BYM-338, BYM338, BYM 338, Anti-ACVR2B Reference Antibody
Reactivity
Human
Verified Activity
Immobilized Human ACVR2B Protein (aa 19-137, His) at 2 μg/mL (30 μL/well) can bind Bimagrumab. The EC50 is 0.005171 μg/mL
verifiedActivity
Application
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Gene ID
Uniprot ID
TargetACVR2B
Chemical Properties
Molecular Weight142.73 kDa
Cas No.1356922-05-8
Antibody Information
IsotypeHuman IgG1 lambda C2
Recommended Isotype Control
Storage & Solubility Information
Storagestore at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy Bimagrumab | purchase Bimagrumab | Bimagrumab cost | order Bimagrumab | Bimagrumab in vivo | Bimagrumab in vitro | Bimagrumab molecular weight